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Available online xxxxA clinical case of fatal HBoV infection in an adult cystic-ﬁbrosis patient awaiting lung transplantation is
reported. The case is important as the genetic background of the underlying disease is congruent with
the background of the sole permissive permanent cell culture CuFi-8 which originates also from a CF pa-
tient donor.
© 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).The human bocavirus (HBoV) is a parvovirus that is associated with
acute and chronic infections of the upper and lower respiratory tract,
persists in some tissues and solid cancers and putatively may play an
aetiologic role in the development of idiopathic lung ﬁbrosis [1–8].
The viral infection can switch between long term periods of viral shed-
ding and silent phases of latency [9]. To date, no animal model exists,
thus studies on the pathology of HBoV infections are limited to clinical
studies, case descriptions, and air-liquid interface cell culture models
that have been shown to mimic some important steps of the infection
cycle [1,7,10–12]. The latter infections models are based on either pri-
mary cells that can be differentiated into organ like tissues fromprimary
cells [1,7,11–13] or CuFi-8 cells [1,10,13]. CuFi-8 is a cell line derived
from a 24 year old female patient suffering from cystic ﬁbrosis; the
cell line carries the mutation pattern ΔF508/ΔF508 (the most common
CF associated mutation) and is an immortalized human epithelial air-
way cell line from the bronchus of the patient; the immortalization
was performed with Weinberg hTERT and HPV-16 E6/E7 [10,14].
This information might be relevant for a current clinical case that
was treated in our hospital in Cologne. The patient was a 24 year old
non-smoking Caucasian cysticﬁbrosis patient. Shewas regularly treated
in our cystic ﬁbrosis outclinics and was deemed to be eligible for lung
transplantation shortly before the fatal clinical episode started. In ad-
vance to the lung transplantation, a microbiological check-up revealedmbH, Krankenhaus Merheim,
t für Pathologie, Ostmerheimer
ildgen).
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al., Fatal HBoV-1 infection in acolonization of the lung with low titres of Aspergillus and a multi-
resistant Pseudomonas aeruginosa strain, combined with allergic asth-
ma, pancreatic insufﬁciency, and malnutrition (BMI 14–15 kg/m2). In
order to overcome the malnutrition, percutaneous endoscopic
gastrostomy (PEG) was required and initiated in our hospital. The pa-
tient started to recover well, episodically required non-invasive ventila-
tion (NIV), but was in a condition stable enough to continue NIV at
home. The night before the patient should have left the hospital she de-
veloped an ARDS unexpectedly and was shifted to our intensive care
unit. During intensive care treatment, despite expected obstipation,
the patient developed massive diarrhea. In order to identify a pathogen
causative for the ARDS, a BAL was performed and analysed for respira-
tory bacteria and viruses. An all-embracingmolecular and microbiolog-
ical diagnostic algorithm was performed as described earlier [15–17],
including molecular screening for human herpesviruses 1–8,
Parechoviruses, Rhino- and Enteroviruses, Adenoviruses, Inﬂuenza A and
B virus including H1N1, Human metapneumovirus, respiratory syncytial
virusAandB,Coronaviruses229E,OC43,HKU-1,NL63, parainﬂuenzaviruses
1–4, mumps andmeasles, and human bocavirus,Mycoplasma pneumoniae,
Chlamydophila pneumoniae, Legionella pneumophila, and Bordetella pertussis,
but revealed human bocavirus as the sole pathogen detectable in the
BAL during the fatal clinical ﬂare of the ARDS. Detailed protocols for
the diagnostic procedures were published previously [1,9,16–18].
Moreover, any attempts to culture further respiratory pathogens in-
cluding Mycobacterium tuberculosis and atypical mycobacteria re-
vealed negative results.
Although the clinical course could have been triggered by the Pseu-
domonas aeruginosa or Aspergillus colonization and no Pseudomonas
cepacia infection was differentially excluded, the most likely explana-
tion for the fatal outcome remains the sole infection with human
bocavirus. In this context it is important to note, that the patient wasthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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donor of the CuFi-8 cell line, at the time point of death was 24 years of
age. It is important to mention, that the BAL was characterized by seri-
ous bleeding, which may have contributed to the clinical outcome.
This bleeding is another parallel to the CuFi-8 cells: The cells are permis-
sive for HBoV if they are seeded to ﬁlter membranes and differentiated
to pseudostratiﬁed air-liquid interface cultures; thereby, they fall dry
and develop a mucus layer on top, while receiving nutrition from the
basal medium. If those air-liquid interface cultures are infected with
HBoV they develop a serious cytopathic effect and may become
“leaky”, i.e. the basal cell culture medium passes the membrane,
which can be compared to the clinical bleeding. The fact that age, sex,
and genetic phenotype for the patient and the permissive CuFi-8 cell
culture were equal solicits the cautious conclusion that the patient
was highly permissive for the HBoV infection and died because of the
serious damages the virus initiated. This hypothesis is further supported
by the fact that the patient suffered fromdiarrhea, although cystic ﬁbro-
sis in concert with pancreatic insufﬁciency is generally accompanied by
obstipation. In this context it is important tomention that HBoV-1 is not
generally associated with diarrhea but is observed in HBoV-2 and 3 in-
fections [19–22]; however, HBoV-1 can be shed via the gastrointestinal
route after swallowing and was repeatedly found in colorectal malig-
nancies [23,24]. Unfortunately, due to the fact that the clinical course
progresses so rapidly, and that the clinical colleagues were not aware
of the parallels between the genetic background of the CuFi-8 cells
and the patient, no further clinical specimenwere collected for scientiﬁc
purposes, thus no further laboratory investigations could be performed,
although this would not have changed the clinical decisionmaking. This
is a considerable limitation of our report,which in our view still contains
important hints regarding the pathogenesis of HBoV.
Taking into account the fact that it remains formally difﬁcult to attri-
bute clinical causalities to human bocavirus as previously discussed by
Martin [25] and Byington [26], a permissive animal model for studying
HBoV pathology would be a great advantage. However, although exclu-
sively investigating a clinical cohort, Byington [26] and coworkers have
unintendedly conﬁrmed the assumption that HBoV is indeed a true
pathogen rather than a blind and silent passenger [27], which was fur-
ther conﬁrmed by our recent translation study in which we have
shown that HBoV-1 induces a proﬁbrotic and procancerogenic cyto-
kines expression in vivo and in vitro [1].
We also have to critically discuss the putative link between the CF
genotype of the patient and the cell culture and its relation to the severe
outcome of the HBoV infection. So far it remains a matter of speculation
if there is a causality between these co-incidences or if the clinical case
was just a rare event that was congruent to our observations in cell cul-
ture. However, it remains possible that such a causative link exists and
therefore this clinical case presentation is intended to trigger further re-
search in this direction.
As a consequence, more detailed clinical studies that focus on the
high risk group of cystic ﬁbrosis patients suffering fromHBoV infections
are required, and it needs to be tested in vitro if cystic ﬁbrosis speciﬁc
factors contribute to a more severe clinical course of the HBoV infection
of those patients.Ethical approval
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